New York, NY 2/3/2009 4:00:00 PM
News / Health & Wellness

Lawyer Central Warns Consumers about Gadolinium Contrast Agent Health Risk

Lawyer Central has recently updated its Gadolinium Contrast Dye resources, a comprehensive source of information that explains the medical and legal issues currently surrounding MRI contrast agents containing gadolinium. Gadolinium based contrast agents have been the subject of numerous lawsuits that allege that the manufacturers of these products failed to warn consumers about its risks and failed to adequately test them. As a result of this alleged negligence on the part of gadolinium contrast dye manufacturers, individuals with preexisting kidney conditions have been injected with gadolinium contrast agents prior to undergoing MRIs. In some individuals, this has led to the development of a rare and potentially fatal condition known as Nephrogenic Systemic Fibrosis.

If you or a loved one has been harmed by a gadolinium contrast agent, visit Lawyer Central's Gadolinium Contrast Dye Resources to learn more about your legal rights. Gadolinium attorneys are working to help victims recover compensation for medical bills, lost wages, pain and suffering, and other damages. To learn how a gadolinium lawyer can help you, fill out the free case evaluation form on the right side of the page.

Gadolinium contrast agents enhance the quality of MRI images in order to help medical professional detect abnormalities and make diagnoses. However, when MRI patients with kidney problems are unable to flush the gadolinium out of their systems, prolonged exposure to this toxic substance can have serious health consequences. Individuals who are severely affected by Nephrogenic Systemic Fibrosis (NSF) may be unable to fully extend their arms, hands, legs and feet and lose mobility as a result. Symptoms of this disease include hardening of the skin, joint stiffness, yellow spots on the eyes, and muscle weakness. There is no known cure for NSF at this time.

GE Healthcare, Bayer HealthCare Pharmaceuticals, Tyco/Mallinckrodt and Bracco Diagnostics are the manufacturers of the five Food and Drug Administration (FDA) approved gadolinium contrast agents currently available. Hundreds of NSF victims and their families have filed state and federal lawsuits against these makers of gadolinium contrast dyes for their injuries. Visit Lawyer Central today if you feel that you may be eligible to participate in a gadolinium lawsuit.

About Lawyer Central

The Lawyer Central Network is an exclusive nationwide network of attorneys highly dedicated to their unique areas of practice, including gadolinium contrast dye litigation. Lawyer Central is emerging as the leading public relations and mixed media marketing organization for fast-growing law firms and forward-thinking attorneys. Lawyer Central membership includes a variety of media exposure ranging from practice area video filming, through interviews and complete public relations and internet relations management.